Total Payments
$25,760
2024 Payments
$18,545
Companies
14
Transactions
92
Medicare Patients
1,018
Medicare Billing
$74,611
Payment Breakdown by Category
Consulting$17,000 (66.0%)
Other$7,625 (29.6%)
Food & Beverage$1,004 (3.9%)
Gifts$74.91 (0.3%)
Education$56.44 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,000 | 5 | 66.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,125 | 3 | 23.8% |
| Honoraria | $1,500 | 1 | 5.8% |
| Food and Beverage | $1,004 | 44 | 3.9% |
| Gift | $74.91 | 36 | 0.3% |
| Education | $56.44 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ASCEND THERAPEUTICS US, LLC | $25,063 | 57 | $0 (2024) |
| AbbVie Inc. | $260.35 | 12 | $0 (2021) |
| Vertical Pharmaceuticals, LLC | $78.70 | 4 | $0 (2018) |
| TherapeuticsMD, Inc. | $65.75 | 3 | $0 (2020) |
| Allergan Inc. | $51.42 | 3 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $40.12 | 2 | $0 (2017) |
| AMAG Pharmaceuticals, Inc. | $40.09 | 2 | $0 (2019) |
| PFIZER INC. | $31.51 | 2 | $0 (2017) |
| CooperSurgical, Inc. | $27.50 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $23.51 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,545 | 9 | ASCEND THERAPEUTICS US, LLC ($18,505) |
| 2023 | $5,236 | 5 | ASCEND THERAPEUTICS US, LLC ($5,236) |
| 2022 | $1,167 | 20 | ASCEND Therapeutics US, LLC ($1,167) |
| 2021 | $47.87 | 3 | AbbVie Inc. ($20.39) |
| 2020 | $40.05 | 2 | TherapeuticsMD, Inc. ($40.05) |
| 2019 | $302.12 | 14 | AbbVie, Inc. ($205.03) |
| 2018 | $234.83 | 29 | ASCEND Therapeutics US, LLC ($143.76) |
| 2017 | $187.20 | 10 | Vertical Pharmaceuticals, LLC ($40.90) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Women's Health | ||||||
| 11/12/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Biological | ||||||
| 05/13/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Women's Health | ||||||
| 04/22/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Women's Health | ||||||
| 04/09/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Women's Health | ||||||
| 03/27/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Women's Health | ||||||
| 03/27/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: Women's Health | ||||||
| 02/13/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $4.95 | General |
| Category: Women's Health | ||||||
| 11/01/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Women's Health | ||||||
| 10/18/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $114.35 | General |
| Category: Women's Health | ||||||
| 09/19/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.45 | General |
| Category: Women's Health | ||||||
| 07/14/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Women's Health | ||||||
| 06/14/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $121.07 | General |
| Category: Women's Health | ||||||
| 12/22/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Women's Health | ||||||
| 12/21/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $3.96 | General |
| Category: Women's Health | ||||||
| 11/16/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.45 | General |
| Category: Women's Health | ||||||
| 11/07/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $3.96 | General |
| Category: Women's Health | ||||||
| 10/27/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $3.96 | General |
| Category: Women's Health | ||||||
| 09/26/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.99 | General |
| Category: Women's Health | ||||||
| 09/13/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $1.98 | General |
| Category: Women's Health | ||||||
| 08/16/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $3.96 | General |
| Category: Women's Health | ||||||
| 06/30/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $3.96 | General |
| Category: Women's Health | ||||||
| 06/15/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $4.95 | General |
| Category: Women's Health | ||||||
| 06/01/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $2.00 | General |
| Category: Women's Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 311 | 357 | $118,620 | $26,686 |
| 2022 | 6 | 233 | 275 | $77,052 | $17,800 |
| 2021 | 5 | 238 | 286 | $67,335 | $14,859 |
| 2020 | 7 | 236 | 277 | $67,503 | $15,267 |
Total Patients
1,018
Total Services
1,195
Medicare Billing
$74,611
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 126 | $50,400 | $9,462 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 52 | $20,800 | $5,212 | 25.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 92 | 92 | $11,040 | $3,944 | 35.7% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 28 | 28 | $14,000 | $3,093 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $13,300 | $2,448 | 18.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 26 | 26 | $2,080 | $1,267 | 60.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $7,000 | $1,258 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 141 | $45,007 | $9,253 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,700 | $2,290 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 22 | $8,806 | $1,859 | 21.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 14 | 14 | $7,000 | $1,549 | 22.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 40 | 40 | $4,020 | $1,483 | 36.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 38 | 38 | $4,520 | $1,366 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 130 | $39,015 | $7,039 | 18.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 20 | 24 | $12,000 | $2,560 | 21.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 61 | 61 | $6,100 | $2,188 | 35.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 54 | 54 | $6,480 | $1,855 | 28.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,741 | $1,217 | 32.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 112 | $33,610 | $5,763 | 17.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 53 | 53 | $6,360 | $2,217 | 34.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 52 | 52 | $5,200 | $2,110 | 40.6% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 14 | 14 | $7,000 | $1,566 | 22.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 21 | $8,403 | $1,417 | 16.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $3,081 | $1,218 | 39.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,851 | $975.27 | 25.3% |
About Dr. Steven Rabin, MD
Dr. Steven Rabin, MD is a Obstetrics & Gynecology healthcare provider based in Burbank, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366526295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Rabin, MD has received a total of $25,760 in payments from pharmaceutical and medical device companies, with $18,545 received in 2024. These payments were reported across 92 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($17,000).
As a Medicare-enrolled provider, Rabin has provided services to 1,018 Medicare beneficiaries, totaling 1,195 services with total Medicare billing of $74,611. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology, Gynecology
- Location Burbank, CA
- Active Since 10/25/2006
- Last Updated 08/17/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366526295
Products in Payments
- ESTROGEL (Drug) $24,930
- Orilissa (Drug) $205.03
- SPRIX (Drug) $125.15
- DIVIGEL (Drug) $78.70
- IMVEXXY (Drug) $65.75
- LO LOESTRIN FE (Drug) $51.42
- Kyleena (Drug) $40.12
- INTRAROSA (Drug) $40.09
- Lupron (Drug) $34.93
- Veozah (Drug) $23.51
- Bonjesta (Drug) $22.37
- ThinPrep (Device) $21.16
- ORILISSA (Drug) $20.39
- ESTRING (Drug) $18.37
- Xulane (Drug) $17.66
- Paragard T 380A (Drug) $16.37
- MYFEMBREE (Drug) $16.35
- PVC (Drug) $13.14
- Paragard (Device) $11.13
- PROTIVA (Drug) $8.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Burbank
Dr. David Ahdoot, Md, MD
Obstetrics & Gynecology — Payments: $16,168
Obstetrics & Gynecology $16,168
Dr. Jose Medrano, Md, MD
Obstetrics & Gynecology — Payments: $11,889
Obstetrics & Gynecology $11,889
Carlos Flores, M.d, M.D
Obstetrics & Gynecology — Payments: $10,477
Obstetrics & Gynecology $10,477
Dr. Vardui Asiryan, M.d, M.D
Obstetrics & Gynecology — Payments: $10,151
Obstetrics & Gynecology $10,151
Jose Aranez, Md, MD
Obstetrics & Gynecology — Payments: $8,228
Obstetrics & Gynecology $8,228
Dawn Cashie, Md, MD
Obstetrics & Gynecology — Payments: $4,705
Obstetrics & Gynecology $4,705